Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | D N ASSOCIATES | Awarded | 10 | ₹1.0 L |
| 2 | Schedule 2 | BIOGEN SERUMS PRIVATE LIMITEDLikely | Evaluation in Progress | 6 | ₹15,096 |
| 3 | Schedule 3 | JVB MEDICARE PRIVATE LIMITED | Awarded | 8 | ₹57,947.40 |
| 4 | Schedule 4 | D N ASSOCIATES | Awarded | 4 | ₹17,010 |
| 5 | Schedule 5 | D N ASSOCIATES | Awarded | 13 | ₹91,542 |
Tender Value
₹25.0 L
EMD Value
Exempted
Closing Date
24 Jan 2026, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
13920Enzalutamide 40 mg Tab
10675Artesunate 60 mg Inj
16725Vitamins D3 Drops 800 IUper ml Bottof 15 ml
NIVper 1329Tab Pyridoxine 40mg
NIVper 2917Acebrophylline 100 mg with N Acetyl cystein
010257Diclofenac sodium 50mg enteric coated Tab
010258Diclofenac 25mgper ml IP Inj 3 ml
13248Gentamycin sulphate Inj IMper IV 40mgper ml2ml
013209Amoxycillin oral susp containing Amoxycillin
013260Cotrimoxazole 60ml Susp Each 5ml contains
012705Vitamin B complex with a minimum concentration
29001708Povidone iodine 5percentage skin ointment
0114342 Propanol 45gm1 Propanol 30gm Ethyl
013222Amikacon Sulphate 250mgper 2ml Inj
013253Metronidazole Inj for IV use contaning 500mg
12411Modafinil 100mg Tab
NIVper 1521Prucalopride 2 mg Tab
NIVper 3794Tab Tamsulosin 0 point4 mg with Dutasterid
NIVper 425Telmisartan 40 mg with Amlodipine 5 mg Tab
010531Divalproate 500mg Tab
010644Pyrazinamide 0 point5 gm Tab
0114342 Propanol 45gm1 Propanol 30gm Ethyl hexadecy
010648Levofloxacin 250mg Tab
010259Ibuprofen 200 mg Tab Bid Number : GEM/2025/B/7010881 Dated : 03-01-2026 Bid Document 1/30
8724853
GEM/2025/B/7010881
Two Packet Bid
13920Enzalutamide 40 mg Tab
Maharashtra; Surendranagar, Gujarat; Lucknow, Uttar Pradesh; Lucknow
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹12 L
₹48 L
10%
PCDA, LUCKNOW, PCDA Lucknow, Department of Military Affairs, Indian Army, Ministry of Defence, (Pcda Lucknow)
Exempted
24 Jan 2026
3 Jan 2026
24 Jan 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | 13920Enzalutamide 40 mg Tab | 3,600 | No | DGLPMS | 45 |
| 2 | 10675Artesunate 60 mg Inj | 1,020 | VIAL | DGLPMS | 45 |
| 3 | 16725Vitamins D3 Drops 800 IUper ml Bottof 15 ml | 4,380 | Bott | DGLPMS | 45 |
| 4 | NIVper 1329Tab Pyridoxine 40mg | 27,000 | No | DGLPMS | 45 |
| 5 | NIVper 2917Acebrophylline 100 mg with N Acetyl cystein | 43,800 | No | DGLPMS | 45 |
| 6 | 010257Diclofenac sodium 50mg enteric coated Tab | 27,600 | No | DGLPMS | 45 |
| 7 | 010258Diclofenac 25mgper ml IP Inj 3 ml | 10,800 | Amp | DGLPMS | 45 |
| 8 | 13248Gentamycin sulphate Inj IMper IV 40mgper ml2ml | 2,640 | Amp | DGLPMS | 45 |
| 9 | 013209Amoxycillin oral susp containing Amoxycillin | 198 | No | DGLPMS | 45 |
| 10 | 013260Cotrimoxazole 60ml Susp Each 5ml contains | 90 | No | DGLPMS | 45 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8724853.pdf
GEM_BID
bbqr_2025-12-17-09-16-19_877dd93686e8c1dbbe9e9479fff99fa8.pdf
BOQ
boq_item_sample_file_2025-12-17-09-16-19_48306548a92bb6acdc1f97f7e0960a12.csv
BOQ
BBQR_5610d94c-9e57-46e2-ae691765944143881_MSPCmemb2.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
BBQR_5610d94c-9e57-46e2-ae691765944143881_MSPCmemb2.pdf
GEM_OTHER • 0.18 MB
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .